Kiser, Jennifer J.
,
Lu, Darlene
Rosenkranz, Susan L.
Morse, Gene D.
DiFrancesco, Robin
Sherman, Kenneth E.
Butt, Adeel A.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UM1AI068636)
Statistical and Data Management Center (UM1AI68634)
Merck
University of Buffalo Pharmacology Specialty Laboratory (UM1AI106701)
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK082621)
Article History
First Online: 5 September 2017
Compliance with Ethical Standards
:
: Jennifer J. Kiser has no conflict of interest to declare. Darlene Lu has no conflict of interest to declare. Susan L. Rosenkranz has no conflict of interest to declare. Gene D. Morse has no conflict of interest to declare. Robin DiFrancesco has no conflict of interest to declare. Kenneth E. Sherman receives research support (paid to institution) from Merck, Bristol Myers Squibb, AbbVie, and Gilead. Adeel A. Butt receives research support (paid to institution) from Gilead and Merck.
: The project described was supported by Award Number UM1AI068636 from the National Institute of Allergy and Infectious Diseases, the Statistical and Data Management Center (UM1AI68634), Merck & Co, Inc., Kenilworth, NJ, USA, the University at Buffalo Pharmacology Specialty Laboratory (UM1AI106701-01, CRB-SSS-S-12-002819, BRS-ACURE-S-12-002537), and K23 DK082621 (J. Kiser). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.